Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial Article

Industry Collaboration International Collaboration

cited authors

  • Heerspink, Hiddo J. L.; Birkenfeld, Andreas L.; Cherney, David Z. I.; Colhoun, Helen M.; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E.; Rosas, Sylvia E.; Rossing, Peter; Skyler, Jay S.; Tuttle, Katherine R.; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F.; Kolkhof, Peter; McGill, Janet B.

authors

Publication Date

  • October 26, 2023

webpage

published in

category

keywords

  • Albuminuria
  • Chronic kidney disease
  • Finerenone
  • Type 1 diabetes

volume

  • 204